REF: 2038 /31 - 7 -2013

      
BRFAA is interested in employing a Post-doctoral fellow for a research programme entitled “PIK3CA Oncogenic Mutations in Breast and Colon Cancers: Development of Targeted Anticancer Drugs and Diagnostics”. The position is funded by the “Greek Ministry of Education” in the context of the “SYNERGASIA” grant program. The post-doctoral researcher will participate in the pharmacological assessment of candidate drugs for targeting the mutated forms of the cancerous PI3Kα protein, in the development of methods for the quantification of biomarkers and in metabolism and toxicity studies.
The candidates should have a Diploma and PhD in Chemistry, Biochemistry, Pharmacy, Biology or related discipline, excellent knowledge of the English language and computer skills.

Additionally the following skills and experience is desired from the ideal candidate:

• Practical experience in bioanalytical chemistry with the use of modern mass spectrometry based analytical techniques (LC/MS/MS, nanoLC/nanoESI MS, HPLC) and protocols used for protein/peptide extraction and subsequent quantification.
• Experience in in vitro and in vivo methods for drug metabolism studies.
• Experience in pre-clinical or clinical pharmacokinetic studies and with the use of laboratory animals. Experience with the development and use of pre-clinical models of disease and assessment of anticancer drugs.
• Experience in cell culture techniques and viability assays.
• Prior experience in cancer studies and/or biomarker analysis is desired.

The position is immediately available and offered for one year. Interested candidates should submit their CV and cover letter to the Secretariat of BRFAA (Soranou Efesiou 4, 11527 Athens, Attention: Personnel Department) including the names of three scientists that can provide a letter of reference until 25-8-2013.

For more information please contact by e-mail at ctamvakop@bioacademy.gr,  by phone at 210-6597475, or visit the lab's website here.

                                                                                                      
THE GENERAL DIRECTOR

ATHANASIOS TSOUROPLIS